Kyowa Kirin To Offload Selected Mature Portfolio To Grünenthal

New JV Set For '26 Buy-Out

Kyowa Kirin and Grünenthal
Grünenthal and Kyowa Kirin enter JV for Japanese firm's established medicines • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip